Lucy Shapiro

Lucy Shapiro

Stanford University School of Medicine

For a 55-year career in biomedical science—honored for discovering how bacteria coordinate their genetic logic in time and space to generate distinct daughter cells; for founding Stanford’s distinguished Department of Developmental Biology; and for exemplary leadership at the national level

The 2025 Lasker~Koshland Special Achievement Award in Medical Science honors Lucy Shapiro (Stanford University School of Medicine) for an esteemed 55-year career in biomedical science. Shapiro discovered how bacteria coordinate their genetic logic in time and space to generate two distinct daughter cells. She founded Stanford’s Department of Developmental Biology and, with the same unique vision that has guided her research, built it into a distinguished entity that percolates with original questions that guide investigations by world-class faculty. An articulate and compelling speaker, Shapiro has advised several U.S. administrations about biological warfare and emerging infectious diseases, offering exemplary leadership at the national level. Concerned about the rise of antibiotic resistance, she launched two biotech companies whose novel approaches have produced drugs for use in humans and an agent that quashes an agricultural pest.

An independent thinker

Since childhood, Shapiro has forged her own path, unconstrained by others’ expectations. Her local high school could not sufficiently stimulate her keen and lively mind, so her parents suggested that she audition for the High School of Music and Arts (now the Fiorello H. LaGuardia High School). After all, she had taken piano lessons since age 4.

Shapiro had a different idea. She secretly taught herself how to draw and, on the application, checked “art” rather than “music.” She lugged her portfolio of drawings—pencil sketches of city streets and country villages, a colored-pen rendition of an aquarium filled with exotic fish—to the entrance exam and gained admission.

Several years later, she majored in fine arts and biology at Brooklyn College, heading toward a career in medical illustration. At a show of her paintings, she encountered physical chemist Theodore Shedlovsky, who bought one and, later, convinced her to take an organic chemistry course. This experience catapulted her into an enthralling sphere of logic and intellectual rigor, abundant with visually rich molecules. Enchanted by the notion that these miniscule objects performed life’s essential tasks, she gravitated toward molecular biology and began working in the lab run by J. Thomas August and Jerard Hurwitz at New York University School of Medicine.

In 1967, soon after earning her Ph.D. at the Albert Einstein College of Medicine, she accepted a faculty position there and dove into the literature to formulate what she considered a timely and far-reaching biological question. The one that she posed anchored her work for the next half century: How do cells translate their linear genetic code into coordinated biochemical activities in three dimensions?

To probe this issue, Shapiro scouted for a simple organism that might hold answers. To tackle the spatial element, she sought a creature that displays distinguishable structures at each end—and that produces distinct daughter cells. She landed on the bacterium Caulobacter crescentus. When it splits, one of its progeny possesses a stalk that secures it to a surface and the other carries a flagellum that propels it to a new location before it settles down to reproduce. Shapiro aimed to discern how this microbe’s genome governs this asymmetric division.

Shapiro’s approach caught the attention of leaders at Stanford University, who were looking for someone to head a new department of developmental biology. They recognized that she was grappling with the ultimate issue in that subject area: how a single cell and its genetic cache specifies instructions for cells that are programmed differently, an achievement that undergirds multicellular life. Shapiro was an unorthodox choice, given that multicellular animals such as flies and worms—not unicellular bacteria —undergo development. But Stanford appreciated her brilliance, charisma, and leadership qualities, and lured her from Columbia, where she had taken a faculty position several years earlier. At the helm, she recruited visionary investigators who were also opening research arenas. Stanford’s Department of Developmental Biology has flourished. Out of the 28 tenured faculty in this department since its inception in 1989, 14 have been elected to the National Academy of Sciences.

Space for new ideas

Conventional wisdom held that bacteria resemble scrambled bags of drifting enzymes and structural proteins that also harbor a floating chromosomal tangle. Yet, in 1993, Shapiro found that chemoreceptors, proteins that sense the external environment, cluster at the cell poles not only in C. crescentus, but in the laboratory workhorse, Escherichia coli.

Many years later, she identified a protein that not only homes to a particular spot, but does so at a specific point in the Caulobacter cell’s life cycle—right after it begins copying its DNA. This protein spurs a key regulator that Shapiro discovered, CtrA, to thwart the initiation of DNA replication. The system, she observed, ensures that the cell duplicates its genetic material only once per division.

She unearthed numerous other strategies by which the bacterium coordinates its tasks. For instance, as the DNA-copying machine moves along, it creates new, naked strands that initially lack chemical adornments called methyl groups. Consequently, recently made DNA is methylated on only one strand of its double helix, whereas the original, older DNA bears these embellishments on both strands. The methylation state influences the activity of several genes whose products play central roles in cell division and differentiation into stalked or swimmer cells, so an entire web of genes turns on and off—with precision—as the replication machinery travels. Sequential changes in the methylation state of the chromosome thus drive the cell cycle forward. This setup synchronizes DNA replication with genetic events that undergird subsequent steps, such as the physical separation of the two daughter cells.

Gradually, Shapiro filled in her picture of how Caulobacter integrates specific molecular movements and behaviors in space as well as time. For instance, the cell destroys CtrA in the half that is destined to become the stalked daughter, liberating it to begin DNA replication immediately upon starting its independent life. In the meantime, CtrA quells this process in its sister, which must swim to a new home before beginning to divide. This sharp segregation underscored the misconception that bacteria contain a chaotic soup of proteins.

Shapiro found that bacterial chromosomes, too, demonstrate exquisitely tuned physical choreography—and they adhere to a much higher degree of spatial organization than previously believed. Rather than wafting randomly here and there, they relocate with timed precision to designated spots in daughter cells before division even finishes. As soon as DNA is made, it harpoons across the cell to its new residence in the future swarmer cell. As replication continues, DNA spools out and homes to its destination, exactly opposite to where it came from.

LUCY SHAPIRO

Shapiro’s research upended conventional wisdom about bacteria.

Eventually, Shapiro would show—with Stanford colleague William E. Moerner (2014 Nobel Prize in Chemistry)—that membrane-less organelles foster some of Caulobacter’s methodical conduct. For example, rapid and selective entry and exit of particular molecules into and out of compartments at each pole gather distinct subsets of proteins such that each daughter inherits a set of regulatory molecules that dictates its developmental fate.

Since 1995, Shapiro has collaborated closely with physicist Harley McAdams (Emeritus, Stanford University School of Medicine). They began applying principles of electrical circuitry to complex genetic networks, noting that both types of systems must reliably operate under changing internal and external conditions. This advance stands as an early example of systems biology, which deploys computational tools to decipher how living systems function. Shapiro and McAdams integrated their labs to spark fruitful interactions and fresh insights among physicists, biochemists, electrical engineers, and geneticists, thus manifesting the power of cross-disciplinary research, which broke ground at the time.

Along the way, Shapiro has trained 71 graduate students and postdoctoral fellows, more than 30 of whom have become faculty members at research institutions around the world; two dozen of them are running Caulobacter labs.

Lucy Shapiro

Shapiro has taken her expertise outside of the lab to advise multiple presidential administrations on bioterrorism, antibiotic resistance, and emerging infectious diseases.

Applying expertise to benefit humanity

Shapiro has also applied her influence and experience in the broader world. By the late 1990s, she was growing increasingly concerned about threats from the microbial realm and, in 1998, President Clinton invited her to the White House to speak to his cabinet about biological warfare. The evening before the meeting, her presentation was vetted and she was reminded that she had five minutes—no more—to talk.

When her turn came, she decided that the next moments of her life presented an unprecedented opportunity, and she went off script. She told Clinton that Nature is a better genetic engineer than any bioterrorist. He asked for an example, so she gave an impromptu lesson on how a harmless strain of E. coli turned into the gastrointestinal pathogen E. coli 0157 by picking up a gene from a different disease-causing bacterium. Responding effectively to a germ, she emphasized, requires the same strategy regardless of whether it emerges from a garage or the environment. She lobbied Clinton and, later, the George W. Bush administration, for federal financing to fund basic research that would illuminate the natural processes that underpin the development of such scourges and deduce how best to protect ourselves from them.

Part of the solution relates to the rising tide of antibiotic resistance and the associated need for new classes of drugs—a situation that pharmaceutical companies are struggling to address. She and chemist Stephen Benkovic (Pennsylvania State University) teamed up to conceive an unconventional scheme with which to confront this challenge. They developed boron- rather than carbon-based compounds, which defied standard pharmaceutical thinking, as boron on its own is toxic. They established Anacor Pharmaceuticals in 2002, which has produced two FDA-approved, topical drugs, one of which subdues ectopic dermatitis and the other fights fungal infections. She and Benkovic have since pivoted to agriculture to co-found a second company, Boragen (now 5Metis), one of whose compounds attacks a fungus that devastates banana plants.

With confidence and ingenuity, Shapiro has sparkled as an investigator, an academic leader, an advocate for basic research, and an entrepreneur. Consistently ahead of her time on all fronts, she has made exceptional contributions to our understanding of cellular life and to the scientific community.

by Evelyn Strauss

Research Articles

Maddock JR and Shapiro L. (1993). Polar location of the chemoreceptor complex in the Escherichia coli cell. Science. 259, 1717-1723.

McAdams HH and Shapiro L. (1995). Circuit simulation of genetic networks. Science. 269, 650-656.

Domian IJ, Quon KC, and Shapiro L. (1997). Cell type-specific phosphorylation and proteolysis of a transcriptional regulator controls the G1-to-S transition in a bacterial cell cycle. Cell. 90, 415-424.

Laub MT, McAdams HH, Feldblyum T, Fraser CM, and Shapiro L. (2000). Global analysis of the genetic network controlling a bacterial cell cycle. Science. 290, 2144-2148.

Thanbichler M and Shapiro L. (2006). MipZ, a spatial regulator coordinating chromosome segregation with cell division in Caulobacter. Cell. 126, 147-162.

Wang J, Moerner WE, and Shapiro L. (2021). A localized adaptor protein performs distinct functions at the Caulobacter cell poles. Proc. Natl. Acad. Sci. USA. 118, e2024705118.

Biographical Articles

Shapiro L. (2012). Life in a three-dimensional grid. J. Biol. Chem. 287, 38289-38294.

Shapiro L. (2022). A half century defining the logic of cellular life. Annu. Rev. Genet. 56, 1-15.

Award Presentation: Craig Thompson

By all reports, Lucy Shapiro developed her independent nature and thoughtful approach to problem solving in childhood. Growing up in New York City, in an immigrant family of limited means, it was soon clear that the local schools could not provide an academic challenge for Lucy. Since she had excelled at the piano since the age of 4, as she prepared for secondary school, her family decided Lucy would apply to The High School of Music and Art, a magnet school. Lucy did not see herself as a future musician. So, without telling her parents, she frequented the public library and taught herself to draw. When she submitted her high school application, she checked “art” rather than “music” as the admissions standard she wished to apply through. Her submitted portfolio of self-taught artwork was what gained her admission.

Following high school, Lucy entered Brooklyn College and undertook a double major in art and biology, planning a career in medical illustration. Her interest in science grew during college, and when the time came, rather than choosing the safe route of pursuing a career as an illustrator, Lucy decided to pursue graduate school in biology. It was the dawn of molecular biology, and Lucy was exposed to the vibrant biologic community. Shapiro spent time during her training not only at NYU and Albert Einstein, but also at Cold Spring Harbor Laboratory where she was introduced to bacterial genetics. Following completion of her PhD, the Chair of the Molecular Biology Department at Albert Einstein offered Lucy a faculty position and advised her to pick a new problem that interested her. At the time, most other molecular biologists were using E. coli as the model organism with which to study genetic processes. Instead, Lucy surprised her new department by picking an obscure bacteria called Caulobacter crescentus to work on. With that choice Lucy began a revolution in biology that still continues.

You see, the classical view of cell division at the time was that a parental cell divided into two identical daughter cells. Lucy chose Caulobacter crescentus because it appeared to be able to divide into two distinct daughter cells under certain circumstances. It was a brilliant decision that has had far reaching implications. Lucy discovered that Caulobacter’s asymmetric division represents an evolutionary strategy that predates multicellularity. In response to environmental cues, the parent cell makes a non-altruistic decision to produce two distinct daughters: a swarmer that becomes motile and moves away to find a new position to live and a stalk cell that stays in place to determine whether the current position remains viable. This strategy promotes the probability of species survival. Through the study of asymmetric cell division, Shapiro defined critical regulatory mechanisms that control the asymmetric fate of the daughter cells including two-component signal transduction, cyclic dinucleotides, methylation, and regulated proteolysis. The multiple layers of regulatory control Lucy and her trainees and collaborators discovered laid the foundation for the field of systems biology. In pursuing this work, Shapiro trained over 70 students and postdocs, over 30 of whom now run independent laboratories.

Taken together, Shapiro’s pioneering research opened the door to universal principles governing cell organization, gene regulation, and developmental biology that apply to all living organisms. Her scientific achievements have earned her numerous awards including the Canada Gairdner International Award, the Linus Pauling Medal, and the National Medal of Science.

But Shapiro’s contributions don’t end there, Lucy has had an equally impactful career in scientific leadership. Ten years after she started her own laboratory, her colleagues asked her to serve as Chair of the department. Four years after that, she became head of the Division of the Biologic Sciences at Albert Einstein. Five years later, she was recruited to re-invigorate the Department of Microbiology and Immunology at Columbia University.

However, Lucy had a vision that extended well beyond microbiology. In 1989, she moved to Stanford to become the Inaugural Chair of a newly created Department of Developmental Biology. It was a bold move for a microbiologist to take over a department being formed to explore how multicellular life developed from a single fertilized egg. But Lucy believed that basic principles discovered in microbial species could be applied to the study of human development and genetics. As Chair, she set the culture for the nascent department, building it into an international model of scientific success. Today of the 28 tenured faculty, 14 are members of the National Academy of Sciences. Through the success of the department and her own foundational work in systems biology, Shapiro also emerged as a leading advocate for interdisciplinary science, helping found BIO-X on the Stanford campus and serving as Director of the Beckman Center for Molecular and Genetic Medicine.

Her leadership extended well beyond Stanford. Following a presentation Shapiro made on antibiotic resistance and bioterrorism at a Cabinet meeting, President Clinton asked her to serve as a Scientific Advisor on antibiotic resistance, bioterrorism, and emerging infectious diseases. During the Bush administration, she continued to play an advisory role for Homeland Security and the Department of State. And Shapiro didn’t just advise on these issues, she also put in place new translational efforts to address antibiotic resistance. Moving outside the academic world, Shapiro partnered with biochemist Stephen Benkovic and biophysicist Harley McAdams to found a biotech company to produce boron-containing antimicrobial compounds. The company they founded, Anacor Pharmaceuticals, produced two FDA-approved drugs, one a widely used antifungal agent. When Anacor was acquired by Big Pharma, Shapiro and Benkovic turned their attention and boron chemistry to address devastating crop diseases in the developing world. Their drug to treat fungal blight has had successful field trials.

There are two standards by which nominees for a Lasker-Koshland Special Achievement Award in Medical Science are judged.
Are the candidate’s contributions to research and scientific statesmanship unique?
Does the candidate’s career engender awe and respect within the biomedical community?
Dr. Lucy Shapiro’s accomplishments do not just meet these two standards but set a new bar for both. As a scientist, she helped pioneer a systems-based approach to fundamental biomedical questions and applied her discoveries to developing important therapeutics in areas as diverse as skin infections and food crop preservation. At a time when the world needs more scientific leadership, Shapiro has set the bar for excellence as a visionary builder of intradisciplinary scientific programs; as a role model and mentor to countless students; and excelled as a national/international advisor on emerging infectious diseases, antibiotic resistance, and bioterrorism.

In short, Dr. Lucy Shapiro is a force of nature.

Acceptance remarks by Lucy Shapiro

Soon after starting my own lab, I made it my goal to discover how a living cell operates in time and space as a chemical machine. At the time—late 1960s—people were not thinking about regulatory mechanisms in 3 dimensions. I wondered how the spatial architecture of the cell is encoded in a linear genetic code. For that, I needed to study the simplest living cell, a bacterial cell, that had obvious spatial architecture—a cell that divided asymmetrically to give different daughter cells: one with a tail-like flagellum that helps it swim and the other with a stalk that anchors it to a surface, That cell surely needs to reorganize itself as a 3D object. The fundamental basis of developmental biology is the use of stem cells that divide to give new types of cells. I reasoned we could address this universal stem cell problem by studying the simple bacterial system that I was exploring.

We found that the bacterial cell indeed has internal architecture. Furthermore, it uses an integrated genetic circuit that functions in time and space to program a cell cycle that replicates not only its DNA but the dynamic organization of the entire cellular machine.

In 1990, I moved to Stanford to build a new Department of Developmental Biology, where faculty would ask the same fundamental questions about how new cell types are generated and organized in space, but using multiple living entities, from bacteria, to worms, to fish, to flies, to mice. With physicist Harley McAdams, we built an interdisciplinary lab of engineers, physicists, biochemists, geneticists and cell biologists, to create models that captured the chemical logic of life.

Then I looked at the precarious state our world is in—with impending consequences of climate change, a growing infectious disease threat, the steady growth of antibiotic resistance. Our world is an interconnected system, like a living cell, and any perturbation to an individual system has consequences throughout the entire system. Life on earth is fragile. Global health is at a tipping point.

So, I initiated a three-pronged approach:

  1. Design and develop new anti-infectives;
  2. Take my message to Washington, where I spoke with Clinton’s Cabinet about the genesis of new infectious agents, both natural and of malevolent human design. Later, in 2019, I addressed the Senate Armed Services committee about antibiotic resistance and the rising risk of pandemics; and
  3. Speak to the public about these issues wherever I could gain an audience, from NPR to high school auditoriums.

Never has the need to speak up been more dire than it is today—at a time of distrust of science and rampant misinformation. Each of us needs to use everything at our disposal to help humanity to survive in our interconnected world.

2025 Special Achievement Award video

Frank Stella. Jasper’s Split Star

From simplicity to complexity: A path to innovation in science and art

Simple reductionist systems can serve as powerful catalysts for unlocking complex innovations in science and art.